(Stroke. 1996;27:891-896.)
© 1996 American Heart Association, Inc.
Articles |
Clinical Relevance of Intracranial Microembolic Signals in Patients With Left Ventricular Assist Devices
A Prospective Study
From the Departments of Neurology (D.G.N., D.G., T.M., E.B.R.) and of Thoracic and Cardiovascular Surgery (C.S., H.H.S.), University of Münster, Münster, Germany, and the University Department of Cardiac Surgery, Royal Infirmary, Glasgow, UK (T.G.M.).
Correspondence to D.G. Nabavi, Department of Neurology, University of Münster, Albert Schweitzer-Str. 33, 48129 Münster, Germany.
Background and Purpose The use of left ventricular assist devices has become an established method in bridging patients with end-stage cardiac failure to heart transplantation. Since thromboembolism is one of the major complications, we undertook this study to evaluate the clinical significance of Doppler microembolic signals (MES) in patients with left ventricular assist devices.
Methods Six patients with left ventricular assist devices were monitored for MES with transcranial Doppler ultrasonography during the first 30 postoperative days. Additionally, repeated (10 per day and patient) and prolonged (3 hours per patient) monitorings were performed to assess the adequacy of the 30-minute recordings. Three observers evaluated 30 randomly assigned monitorings in a blinded fashion to assess the interobserver variability. The relation between MES counts and clinical, radiological, hemostaseological, and pump flow parameters and the predictive value of MES counts regarding the occurrence of embolic events was evaluated.
Results Ten ischemic cerebrovascular accidents and 2 peripheral thromboembolic events occurred during the observation period of 177 days (total incidence, 6.8%). MES were found in 143 of 170 monitorings (84.1%). Their counts were significantly higher on days with clinically manifest embolic events as compared with event-free days (18.5 [3-74] versus 4 [0-52], respectively, median and 95% CI; P<.001, Mann-Whitney). The predictive value of MES counts above 7 per 30 minutes was high (75%). Significant differences in the incidence and counts of MES as well as in the incidence of clinically manifest embolic events were noted among the six patients (all P<.01) without equal differences in anticoagulant treatment or pump flow. Interobserver agreement was high (P=.78 to .89, unpaired Student's t test). Considerable short- and long-term intrapatient variations of MES counts, without consistent pattern, were noted.
Conclusions Serial monitoring for MES is prognostically superior to single monitorings in patients with left ventricular assist devices. In the future, this new application mode may individually guide anticoagulation strategies and even influence the decision regarding early cardiac transplantation versus long-term use of the assist devices.
Key Words: diagnostic imaging • embolism • heart-assist devices • ultrasonics
This article has been cited by other articles:
 |
|
 |
|
  R. Dittrich and E. B. Ringelstein Occurrence and Clinical Impact of Microembolic Signals During or After Cardiosurgical Procedures Stroke, February 1, 2008; 39(2): 503 - 511. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. H. Thoennissen, M. Schneider, A. Allroggen, M. Ritter, R. Dittrich, C. Schmid, H. H. Scheld, E. B. Ringelstein, and D. G. Nabavi High level of cerebral microembolization in patients supported with the DeBakey left ventricular assist device J. Thorac. Cardiovasc. Surg., October 1, 2005; 130(4): 1159 - 1166. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Rinaldi, F. Pagani, F. Gazzoli, A. Alloni, D. Ricci, and M. Vigano Left ventricular assistance from bridge to transplantation to destination therapy. The Pavia experience Eur. Heart J. Suppl., November 1, 2004; 6(suppl_F): F81 - F86. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Fries, P. Innerhofer, W. Streif, W. Schobersberger, J. Margreiter, H. Antretter, and C. Hormann Coagulation monitoring and management of anticoagulation during cardiac assist device support Ann. Thorac. Surg., November 1, 2003; 76(5): 1593 - 1597. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Williams, J. Casher, N. Joshi, T. Hankinson, M. Warren, M. Oz, Y. Naka, and D. Mancini Insertion of a left ventricular assist device in patients without thorough transplant evaluations: a worthwhile risk? J. Thorac. Cardiovasc. Surg., August 1, 2003; 126(2): 436 - 441. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. G. Nabavi, J. Stockmann, C. Schmid, M. Schneider, D. Hammel, H. H. Scheld, and E. B. Ringelstein Doppler microembolic load predicts risk of thromboembolic complications in Novacor patients J. Thorac. Cardiovasc. Surg., July 1, 2003; 126(1): 160 - 167. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. E. Thomas, D. Jichici, R. Petrucci, V. C. Urrutia, and R. J. Schwartzman Neurologic complications of the Novacor left ventricular assist device Ann. Thorac. Surg., October 1, 2001; 72(4): 1311 - 1315. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D.W. Quinn, T.J.J. Jones, and T.R. Graham Mechanical Circulatory Support Sources of Emboli and Neurological Outcome Seminars in Cardiothoracic and Vascular Anesthesia, July 1, 2000; 4(2): 115 - 120. [Abstract] [PDF]
|
|
|
|
 |
|
 I. Di Bella, F. Pagani, C. Banfi, E. Ardemagni, A. Capo, C. Klersy, and M. Vigano Results with the Novacor assist system and evaluation of long-term assistance Eur. J. Cardiothorac. Surg., July 1, 2000; 18(1): 112 - 116. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Schmid, M. Wilhelm, M. Rothenburger, D. Nabavi, M. C. Deng, D. Hammel, and H. H. Scheld Effect of high dose platelet inhibitor treatment on thromboembolism in Novacor patients Eur. J. Cardiothorac. Surg., March 1, 2000; 17(3): 331 - 335. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. R. Wilhelm, J. Ristich, L. E. Knepper, R. Holubkov, S. R. Wisniewski, R. L. Kormos, and W. R. Wagner Measurement of Hemostatic Indexes in Conjunction With Transcranial Doppler Sonography in Patients With Ventricular Assist Devices Stroke, December 1, 1999; 30(12): 2554 - 2561. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. R. Gross Concerning thromboembolism associated with left ventricular assist devices Cardiovasc Res, April 1, 1999; 42(1): 45 - 47. [Full Text] [PDF]
|
|
|
|
|
|
C. Schmid, M. Weyand, D. G. Nabavi, D. Hammel, M. C. Deng, E. B. Ringelstein, and H. H. Scheld Cerebral and Systemic Embolization During Left Ventricular Support With the Novacor N100 Device Ann. Thorac. Surg., June 1, 1998; 65(6): 1703 - 1710. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L Valton, V Larrue, A P. Le Traon, and G Geraud Cerebral microembolism in patients with stroke or transient ischaemic attack as a risk factor for early recurrence J. Neurol. Neurosurg. Psychiatry, December 1, 1997; 63(6): 784 - 787. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. W. Droste, T. Hansberg, V. Kemeny, D. Hammel, G. Schulte-Altedorneburg, D. G. Nabavi, M. Kaps, H. H. Scheld, and E. B. Ringelstein Oxygen Inhalation Can Differentiate Gaseous From Nongaseous Microemboli Detected by Transcranial Doppler Ultrasound Stroke, December 1, 1997; 28(12): 2453 - 2456. [Abstract] [Full Text]
|
|
|
|
|
|
V. L. Babikian, C. A. C. Wijman, C. Hyde, N. L. Cantelmo, M. R. Winter, E. Baker, and V. Pochay Cerebral Microembolism and Early Recurrent Cerebral or Retinal Ischemic Events Stroke, July 1, 1997; 28(7): 1314 - 1318. [Abstract] [Full Text]
|
|
|
|
|
|
D. Georgiadis, A. Lindner, M. Manz, M. Sonntag, P. Zunker, H. R. Zerkowski, and M. Borggrefe Intracranial Microembolic Signals in 500 Patients With Potential Cardiac or Carotid Embolic Source and in Normal Controls Stroke, June 1, 1997; 28(6): 1203 - 1207. [Abstract] [Full Text]
|
|
|
|
|
|
H. S. Markus and J. Molloy Use of a Decibel Threshold in Detecting Doppler Embolic Signals Stroke, April 1, 1997; 28(4): 692 - 695. [Abstract] [Full Text]
|
|